Blue Trust Inc. Cuts Stock Holdings in CVS Health Corporation $CVS

Blue Trust Inc. cut its stake in CVS Health Corporation (NYSE:CVS) by 2.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,831 shares of the pharmacy operator’s stock after selling 290 shares during the period. Blue Trust Inc.’s holdings in CVS Health were worth $678,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of CVS. Commerzbank Aktiengesellschaft FI raised its position in CVS Health by 19.9% in the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 64,971 shares of the pharmacy operator’s stock valued at $4,482,000 after purchasing an additional 10,795 shares in the last quarter. Argyle Capital Management LLC raised its holdings in CVS Health by 0.7% in the second quarter. Argyle Capital Management LLC now owns 30,417 shares of the pharmacy operator’s stock valued at $2,098,000 after acquiring an additional 200 shares in the last quarter. IFP Advisors Inc lifted its stake in CVS Health by 3.7% in the second quarter. IFP Advisors Inc now owns 24,118 shares of the pharmacy operator’s stock worth $1,664,000 after acquiring an additional 862 shares during the last quarter. Callan Family Office LLC grew its holdings in CVS Health by 277.8% during the 2nd quarter. Callan Family Office LLC now owns 121,108 shares of the pharmacy operator’s stock worth $8,354,000 after acquiring an additional 89,053 shares in the last quarter. Finally, Blair William & Co. IL increased its position in shares of CVS Health by 0.9% in the 2nd quarter. Blair William & Co. IL now owns 62,052 shares of the pharmacy operator’s stock valued at $4,280,000 after purchasing an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.22% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on CVS shares. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Wells Fargo & Company increased their price objective on CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Sanford C. Bernstein boosted their target price on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. Finally, Jefferies Financial Group upped their price target on CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a report on Monday, June 30th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $79.80.

CVS Health Trading Up 1.5%

NYSE:CVS opened at $77.89 on Monday. The company has a market capitalization of $98.79 billion, a PE ratio of 21.76, a P/E/G ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $79.20. The stock’s 50 day moving average price is $72.28 and its 200 day moving average price is $67.67. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company’s revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.